nasdaq:aeri
|
1291084
|
Mar 19th, 2024 12:00AM
|
Aerie Pharmaceuticals
|
20K
|
156.00
|
Open
|
|
Mar 18th, 2024 10:44PM
|
Mar 18th, 2024 10:44PM
|
Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care.
Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, dry eye, retinal diseases and other diseases of the eye.
See the future of eye care with Aerie.
|
Open
|
ophthalmic
|
Open
|
4301 Emperor Blvd.
|
Durham
|
NC
|
US
|
27703
|
|
Aerie Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:aeri
|
1291084
|
Mar 18th, 2024 12:00AM
|
Aerie Pharmaceuticals
|
20K
|
156.00
|
Open
|
|
Mar 17th, 2024 10:53PM
|
Mar 18th, 2024 06:33PM
|
Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care.
Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, dry eye, retinal diseases and other diseases of the eye.
See the future of eye care with Aerie.
|
Open
|
ophthalmic
|
Open
|
4301 Emperor Blvd.
|
Durham
|
NC
|
US
|
27703
|
|
Aerie Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:aeri
|
1291084
|
Mar 17th, 2024 12:00AM
|
Aerie Pharmaceuticals
|
20K
|
156.00
|
Open
|
|
Mar 16th, 2024 11:41PM
|
Mar 16th, 2024 11:41PM
|
Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care.
Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, dry eye, retinal diseases and other diseases of the eye.
See the future of eye care with Aerie.
|
Open
|
ophthalmic
|
Open
|
4301 Emperor Blvd.
|
Durham
|
NC
|
US
|
27703
|
|
Aerie Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:aeri
|
1291084
|
Mar 16th, 2024 12:00AM
|
Aerie Pharmaceuticals
|
20K
|
156.00
|
Open
|
|
Mar 15th, 2024 10:32PM
|
Mar 16th, 2024 06:21PM
|
Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care.
Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, dry eye, retinal diseases and other diseases of the eye.
See the future of eye care with Aerie.
|
Open
|
ophthalmic
|
Open
|
4301 Emperor Blvd.
|
Durham
|
NC
|
US
|
27703
|
|
Aerie Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:aeri
|
1291084
|
Mar 15th, 2024 12:00AM
|
Aerie Pharmaceuticals
|
20K
|
156.00
|
Open
|
|
Mar 14th, 2024 11:35PM
|
Mar 15th, 2024 08:06AM
|
Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care.
Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, dry eye, retinal diseases and other diseases of the eye.
See the future of eye care with Aerie.
|
Open
|
ophthalmic
|
Open
|
4301 Emperor Blvd.
|
Durham
|
NC
|
US
|
27703
|
|
Aerie Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:aeri
|
1291084
|
Mar 14th, 2024 12:00AM
|
Aerie Pharmaceuticals
|
20K
|
156.00
|
Open
|
|
Mar 13th, 2024 10:31PM
|
Mar 14th, 2024 11:29AM
|
Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care.
Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, dry eye, retinal diseases and other diseases of the eye.
See the future of eye care with Aerie.
|
Open
|
ophthalmic
|
Open
|
4301 Emperor Blvd.
|
Durham
|
NC
|
US
|
27703
|
|
Aerie Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:aeri
|
1291084
|
Mar 13th, 2024 12:00AM
|
Aerie Pharmaceuticals
|
20K
|
156.00
|
Open
|
|
Mar 12th, 2024 10:29PM
|
Mar 13th, 2024 10:01AM
|
Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care.
Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, dry eye, retinal diseases and other diseases of the eye.
See the future of eye care with Aerie.
|
Open
|
ophthalmic
|
Open
|
4301 Emperor Blvd.
|
Durham
|
NC
|
US
|
27703
|
|
Aerie Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:aeri
|
1291084
|
Mar 12th, 2024 12:00AM
|
Aerie Pharmaceuticals
|
20K
|
156.00
|
Open
|
|
Mar 11th, 2024 10:32PM
|
Mar 12th, 2024 02:25PM
|
Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care.
Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, dry eye, retinal diseases and other diseases of the eye.
See the future of eye care with Aerie.
|
Open
|
ophthalmic
|
Open
|
4301 Emperor Blvd.
|
Durham
|
NC
|
US
|
27703
|
|
Aerie Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:aeri
|
1291084
|
Mar 11th, 2024 12:00AM
|
Aerie Pharmaceuticals
|
20K
|
156.00
|
Open
|
|
Mar 10th, 2024 10:38PM
|
Mar 11th, 2024 09:23AM
|
Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care.
Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, dry eye, retinal diseases and other diseases of the eye.
See the future of eye care with Aerie.
|
Open
|
ophthalmic
|
Open
|
4301 Emperor Blvd.
|
Durham
|
NC
|
US
|
27703
|
|
Aerie Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:aeri
|
1291084
|
Mar 10th, 2024 12:00AM
|
Aerie Pharmaceuticals
|
20K
|
156.00
|
Open
|
|
Mar 9th, 2024 09:36PM
|
Mar 9th, 2024 09:36PM
|
Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care.
Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, dry eye, retinal diseases and other diseases of the eye.
See the future of eye care with Aerie.
|
Open
|
ophthalmic
|
Open
|
4301 Emperor Blvd.
|
Durham
|
NC
|
US
|
27703
|
|
Aerie Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|